129 related articles for article (PubMed ID: 11334015)
1. Latanoprost and the ibopamine test: a year's experience.
Pecori Giraldi J; Mollicone A; Seguto D; Simeone L; Zaccara F
Acta Ophthalmol Scand Suppl; 2000; (232):70-1. PubMed ID: 11334015
[TBL] [Abstract][Full Text] [Related]
2. Effects of latanoprost and unoprostone when used alone or in combination for open-angle glaucoma.
Saito M; Takano R; Shirato S
Am J Ophthalmol; 2001 Oct; 132(4):485-9. PubMed ID: 11589867
[TBL] [Abstract][Full Text] [Related]
3. The effect of latanoprost on aqueous humor PGF2alpha levels in glaucoma patients.
Güven D; Karakurt A; Saban E; Hasiripi H
Int Ophthalmol; 1999; 23(2):91-6. PubMed ID: 11196126
[TBL] [Abstract][Full Text] [Related]
4. Increase in aqueous humor production following D1 receptors activation by means of ibopamine.
Virno M; Taverniti L; De Gregorio F; Sedran L; Longo F
Int Ophthalmol; 1996-1997; 20(1-3):141-6. PubMed ID: 9112178
[TBL] [Abstract][Full Text] [Related]
5. The role of the uveoscleral outflow in the management of pigmentary glaucoma: a 24-month study comparing latanoprost with timolol.
Carpineto P; Ciancaglini M; Zuppardi E; Doronzo E; Mastropasqua L
Acta Ophthalmol Scand Suppl; 2000; (232):54. PubMed ID: 11235538
[No Abstract] [Full Text] [Related]
6. Effects of ibopamine eye drops on intraocular pressure and aqueous humor flow in healthy volunteers and patients with open-angle glaucoma.
Azevedo H; Ciarniello MG; Rosignoli MT; Dionisio P; Cunha-Vaz J
Eur J Ophthalmol; 2003 May; 13(4):370-6. PubMed ID: 12872794
[TBL] [Abstract][Full Text] [Related]
7. Four years later: a clinical update on latanoprost.
Ravinet E; Mermoud A; Brignoli R
Eur J Ophthalmol; 2003 Mar; 13(2):162-75. PubMed ID: 12696636
[TBL] [Abstract][Full Text] [Related]
8. Correlation between individual differences in intraocular pressure reduction and outflow facility due to latanoprost in normal-tension glaucoma patients.
Kondo N; Sawada A; Yamamoto T; Taniguchi T
Jpn J Ophthalmol; 2006; 50(1):20-4. PubMed ID: 16453183
[TBL] [Abstract][Full Text] [Related]
9. Intraocular pressure fluctuations in response to the water-drinking provocative test in patients using latanoprost versus unoprostone.
Susanna R; Medeiros FA; Vessani RM; Giampani J; Borges AS; Jordão ML
J Ocul Pharmacol Ther; 2004 Oct; 20(5):401-10. PubMed ID: 15650515
[TBL] [Abstract][Full Text] [Related]
10. The influence of Latanoprost 0.005% on aqueous humor flow and outflow facility in glaucoma patients: a double-masked placebo-controlled clinical study.
Dinslage S; Hueber A; Diestelhorst M; Krieglstein G
Graefes Arch Clin Exp Ophthalmol; 2004 Aug; 242(8):654-60. PubMed ID: 15241610
[TBL] [Abstract][Full Text] [Related]
11. Latanoprost : an update of its use in glaucoma and ocular hypertension.
Perry CM; McGavin JK; Culy CR; Ibbotson T
Drugs Aging; 2003; 20(8):597-630. PubMed ID: 12795627
[TBL] [Abstract][Full Text] [Related]
12. Latanoprost for the treatment of pediatric glaucoma.
Enyedi LB; Freedman SF
Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S129-32. PubMed ID: 12204709
[TBL] [Abstract][Full Text] [Related]
13. Latanoprost and cholinergic agonists in combination.
Toris CB; Alm A; Camras CB
Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S141-7. PubMed ID: 12204711
[TBL] [Abstract][Full Text] [Related]
14. Intraocular pressure lowering effect of brinzolamide 1.0% as adjunctive therapy to latanoprost 0.005% in patients with open angle glaucoma or ocular hypertension: an uncontrolled, open-label study.
Shoji N; Ogata H; Suyama H; Ishikawa H; Suzuki H; Morita T; Kawai H; Nishimoto H; Nemoto T; Shimizu K
Curr Med Res Opin; 2005 Apr; 21(4):503-8. PubMed ID: 15899098
[TBL] [Abstract][Full Text] [Related]
15. Relation between axial length of the eye and hypotensive effect of latanoprost in primary open angle glaucoma.
Arranz-Marquez E; Teus MA
Br J Ophthalmol; 2004 May; 88(5):635-7. PubMed ID: 15090414
[TBL] [Abstract][Full Text] [Related]
16. Combined therapy of pilocarpine or latanoprost with timolol versus latanoprost monotherapy.
Diestelhorst M; Nordmann JP; Toris CB
Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S155-61. PubMed ID: 12204713
[TBL] [Abstract][Full Text] [Related]
17. A 12-month, randomized, double-masked study comparing latanoprost with timolol in pigmentary glaucoma.
Mastropasqua L; Carpineto P; Ciancaglini M; Gallenga PE
Ophthalmology; 1999 Mar; 106(3):550-5. PubMed ID: 10080213
[TBL] [Abstract][Full Text] [Related]
18. Intraocular pressure after replacement of current dual therapy with latanoprost monotherapy in patients with open angle glaucoma.
Pillunat LE; Larsson LI;
Br J Ophthalmol; 2003 Dec; 87(12):1492-6. PubMed ID: 14660460
[TBL] [Abstract][Full Text] [Related]
19. Effect of previous argon laser trabeculoplasty on the ocular hypotensive action of latanoprost.
Arranz-Marquez E; Teus MA
Graefes Arch Clin Exp Ophthalmol; 2006 Sep; 244(9):1073-6. PubMed ID: 16416130
[TBL] [Abstract][Full Text] [Related]
20. Ibopamine in glaucoma diagnostics: a new pharmacological provocative test.
De Gregorio F; Pecori Giraldi J; Pannarale L; Saccucci S; Virno M
Int Ophthalmol; 1996-1997; 20(1-3):151-5. PubMed ID: 9112180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
